Welcome to our dedicated page for AAQC news (Ticker: AAQC), a resource for investors and traders seeking the latest updates and insights on AAQC stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AAQC's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AAQC's position in the market.
Accelerate Acquisition Corp. (NYSE: AAQC) announced receiving a formal notice of non-compliance from the NYSE on May 25, 2021, due to the late filing of its Quarterly Report on Form 10-Q for Q1 2021. This delay was attributed to new accounting guidance issued by the SEC on April 12, 2021, which prompted many SPACs, including AAQC, to reassess their warrant accounting. Following the notice, AAQC filed its Form 10-Q on May 26, 2021, and is now compliant with NYSE listing requirements.
Accelerate Acquisition Corp. (NYSE: AAQC.U) announced that starting May 10, 2021, unitholders of its initial public offering can trade shares of Class A common stock and warrants separately. The IPO completed on March 22, 2021, with 40,000,000 units. Unseparated units will continue to trade under AAQC.U, while separated shares and warrants will trade under the symbols AAQC and AAQC WS, respectively. No fractional warrants are issued, and brokers must contact Continental Stock Transfer & Trust Company for separation. Forward-looking statements highlight potential uncertainties surrounding this process.
Accelerate Acquisition Corp. has successfully closed its initial public offering, raising $400 million by selling 40 million units at $10 each. The units consist of one share of Class A common stock and one-third of a redeemable warrant, with whole warrants allowing purchase at $11.50 per share. The units will trade on the New York Stock Exchange under ticker symbol AAQC.U, with common stock and warrants expected to trade separately as AAQC and AAQC WS. The offering was managed by UBS Investment Bank.
Accelerate Acquisition Corp. has announced the pricing of its initial public offering (IPO) of 40 million units at $10.00 each, set to trade under the ticker symbol AAQC.U starting March 18, 2021. Each unit includes one share of Class A common stock and one-third of a redeemable warrant, each whole warrant priced at $11.50. The offering is expected to close on March 22, 2021, subject to customary conditions. UBS Investment Bank is the sole book-running manager and holds a 45-day option to purchase an additional 6 million units to cover over-allotments.
FAQ
What is the market cap of AAQC (AAQC)?
